• Viral vIRD Drives RIPK3 Degradation to Control Necroptosis a

  2026-07-23

  Liu et al. unveil a novel viral strategy where orthopoxviruses encode a protein (vIRD) that binds host ubiquitin machinery to selectively degrade RIPK3, suppressing necroptosis and modulating virus-induced inflammation. This mechanistic insight clarifies how viral manipulation of the ubiquitin-proteasome pathway shapes host-pathogen evolution and innate immune responses.

• L-NAME Hydrochloride: Precision NOS Inhibition in Vascular R

  2026-07-23

  L-NAME Hydrochloride (NG-nitro-L-arginine methyl ester) is the gold-standard NOS inhibitor for dissecting nitric oxide signaling and vascular tone regulation. This article translates the latest reference findings into stepwise protocols, troubleshooting strategies, and advanced applications for cardiovascular disease and inflammation models.

• BKT140 (BL-8040): CXCR4 Antagonist for Advanced Cancer Resea

  2026-07-22

  BKT140 (BL-8040) is a potent, highly soluble CXCR4 antagonist that transforms workflows in tumor microenvironment modeling and stem cell mobilization. This guide details optimized protocols, comparative advantages, and troubleshooting insights for researchers targeting CXCR4-driven malignancies.

• hiPSC-Derived Intestinal Organoids Advance Pharmacokinetic S

  2026-07-22

  This study introduces a direct 3D culture protocol for deriving human intestinal organoids from pluripotent stem cells, enabling long-term propagation and functional differentiation. The platform addresses key limitations of traditional in vitro models and offers a robust tool for pharmacokinetic and drug metabolism research.

• BAPTA Calcium Chelator: Precision in Calcium Signaling Studi

  2026-07-21

  BAPTA delivers high-fidelity calcium chelation for dissecting complex intracellular signaling and apoptosis pathways. This guide translates cutting-edge environmental toxicology findings into actionable workflows, troubleshooting strategies, and protocol enhancements for advanced cell signaling research.

• AAPH: Optimizing Lipid Peroxidation Assays with 2,2'-Azobis(

  2026-07-21

  AAPH (2,2'-Azobis(2-methylpropionamidine) dihydrochloride) delivers unmatched control and reproducibility as an erythrocyte hemolysis and lipid peroxidation inducer in in vitro oxidative damage models. This guide translates leading-edge research into actionable workflows, troubleshooting, and protocol enhancements for biomedical labs using APExBIO’s trusted reagent.

• Ferrostatin-1 (Fer-1): Precision in Ferroptosis Assay Design

  2026-07-20

  Ferrostatin-1 (Fer-1) empowers researchers to dissect iron-dependent cell death with nanomolar potency, offering robust, selective inhibition for translational models in cancer biology and neurodegeneration. Learn how to optimize experimental workflows and troubleshoot common pitfalls when leveraging Fer-1 in advanced ferroptosis assays.

• TCAIM Regulates OGDH Proteostasis and Metabolism in Mitochon

  2026-07-20

  Wang et al. identify TCAIM as a DNAJC co-chaperone that selectively targets the mitochondrial enzyme OGDH for degradation, suppressing the TCA cycle and altering cellular metabolism. This work uncovers a post-translational mechanism by which mitochondrial proteostasis directly modulates metabolic flux, with implications for metabolic disease research.

• FAISL lncRNA Inhibits Calpain-2 FAK Cleavage in TNBC Progres

  2026-07-19

  The reference study reveals that lncRNA FAISL promotes triple negative breast cancer progression by inhibiting calpain-2-mediated proteolysis of focal adhesion kinase (FAK), thereby stabilizing FAK protein and enhancing metastatic potential. This mechanistic insight highlights a novel post-translational regulatory axis in TNBC and suggests new directions for targeted intervention.

• ALDH2 Inhibition Triggers Synthetic Lethality in APC-Deficie

  2026-07-18

  The referenced study demonstrates that ALDH2 inhibition, via Disulfiram, induces synthetic lethality in APC-deficient colorectal cancer by elevating ROS and activating the ASK1/JNK pathway. These findings highlight a new vulnerability in APC-mutant tumors, supporting the strategic use of Disulfiram as a research tool in cancer cell death mechanisms.

• Axitinib (AG 013736): Precision Angiogenesis Inhibition Work

  2026-07-17

  Axitinib (AG 013736) empowers researchers with reliable, selective VEGFR blockade for advanced angiogenesis and tumor inhibition studies. This guide delivers workflow enhancements, troubleshooting tips, and key insights from the latest in vitro drug response research to maximize reproducibility and translational relevance.

• Cy3-UTP (SKU B8330): Reliable Fluorescent RNA Labeling for A

  2026-07-17

  This article provides a scenario-driven exploration of Cy3-UTP (SKU B8330) as a high-performance, photostable fluorescent RNA labeling reagent. Benchmarked against experimental challenges in RNA-protein interaction studies, in vitro transcription, and fluorescence imaging, it demonstrates how Cy3-UTP from APExBIO delivers reproducibility and data fidelity for demanding lab workflows.

• Axitinib (AG 013736): Precision Angiogenesis Assays in Cance

  2026-07-16

  Axitinib (AG 013736) enables reliable, selective VEGFR pathway inhibition, empowering advanced angiogenesis and tumor growth studies. This guide details experimental workflows, troubleshooting strategies, and protocol optimizations, building on cutting-edge in vitro evaluation frameworks.

• SVA 3A/2B Proteins Counteract DDX23 via Caspase-Dependent Ap

  2026-07-16

  This study uncovers how Senecavirus A (SVA) proteins 3A and 2B subvert the host restriction factor DDX23 through distinct caspase-dependent apoptotic pathways, identifying key viral and host protein residues that mediate this interaction. These findings illuminate new targets for antiviral intervention and deepen understanding of host-pathogen dynamics relevant to both virology and apoptosis research.

• DNA Damage Drives Selective CUX2 Neuron Loss in Neuroinflamm

  2026-07-15

  This study uncovers how DNA damage burden leads to the selective loss of CUX2-expressing upper cortical layer neurons in neuroinflammatory conditions, particularly multiple sclerosis. By delineating cell type-specific vulnerability and the role of DNA repair mechanisms, the work provides a foundation for future neuroprotection strategies targeting DNA damage in neurodegeneration.

16920 records 1/1128 page Next 12345 下5页 Last page